符合形态限制的Grp94-选择性抑制剂

Hao Xu1, Kyler Pugh1, Brian S J Blagg1

  • 1Department of Chemistry and Biochemistry, Warren Center for Drug Discovery, The University of Notre Dame, 305 McCourtney Hall, Notre Dame, Indiana 46556, United States.

ACS omega
|January 20, 2025
PubMed
概括

研究人员通过修改KUNG65.5开发了新的Grp94抑制剂. 化合物C6选择性地结合Grp94,显示出治疗癌症和玻璃眼等疾病的前景.